/PRNewswire/ Resilia Pharmaceuticals, Inc. announced today that it has brought Neosalus® Cream and Neosalus® Lotion back to the market. Neosalus® Lotion is.
/PRNewswire/ Resilia Pharmaceuticals, Inc. announced today that it has re-launched Solace® Eczema Cream on Amazon® and restored the supply of this product.
/PRNewswire/ After more than 8,000 votes were cast, the winners of the 12th Annual PM360 Pharma Choice Awards have been revealed. PM360, a leading health.
/PRNewswire/ Resilia Pharmaceuticals, Inc. announced the signing today of a license agreement with Pelle Ventures, LLC granting Resilia the rights to make,.
New Dermatology Company Resilia Pharmaceuticals Begins Operations
Specialty Pharma Company Selling Ecoza® (econazole nitrate) topical foam, 1%, Recedo® Topical Gel, Neosalus® Cream, Neosalus® Foam, and Neocera® Advanced Cream Is Focused on Patient Outcomes
News provided by
Share this article
Share this article
NEW YORK and ATLANTA, Dec. 28, 2020 /PRNewswire/ Peak Pharma Commercial Partners, a New York City-based investment fund dedicated to the acquisition and growth of branded, generic and over-the-counter pharmaceutical products (www.peakpharmapartners.com). announced today the creation and start of operations of Resilia Pharmaceuticals, Inc.
Resilia s product line consists of Ecoza
® (econazole nitrate) topical foam, 1%, an antifungal medicine indicated for the treatment of interdigital tinea pedis or athlete s foot; Recedo® topical gel, a leading prescription product for scar management; Neosalus